A novel coronavirus disease (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has affected over 2.3 million people, claiming more than …

Purpose Myositis as a rare manifestation of COVID-19 is only recently being reported. This
review examines the current literature on COVID-19-induced myositis focusing on …

Background In patients with type 2 diabetes, hyperglycaemia is an independent risk factor
for COVID-19-related mortality. Associations between pre-infection prescription for glucose …

Context Invited update on the management of systemic autoimmune Graves disease (GD)
and associated Graves orbitopathy (GO). Evidence acquisition Guidelines, pertinent original …

Aim To explore whether coronavirus disease 2019 (COVID‐19) patients with diabetes and
secondary hyperglycaemia have different clinical characteristics and prognoses than those …

Background and aim. The review aimed to summarize advances in the topic of endocrine
diseases and coronavirus disease 2019 (COVID-19). Methods. Scientific and institutional …

Background In women of reproductive age, polycystic ovary syndrome (PCOS) constitutes
the most frequent endocrine disorder. Women with PCOS are considered to typically belong …

Context While individuals with diabetes appear to be at similar risk for SARS-CoV-2 infection
to those without diabetes, they are more likely to suffer severe consequences, including …

Background The coronavirus disease 2019 (COVID‐19) has evolved into a pandemic
infectious disease transmitted by the severe acute respiratory syndrome coronavirus (SARS …

In November 2019, the Italian Society of Endocrinology (SIE) has published a consensus
statement on the tailoring of glucocorticoid replacement in adrenal insufficiency [1]. A few …